Medline Industries Recalls Reprocessed Abbott Inquiry Steerable Diagnostic Catheters Due to Potential Contamination
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP has issued a Class I recall for 311 reprocessed Abbott Inquiry Steerable Diagnostic Catheters that may contain residual material, posing serious health risks.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on February 24, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Medline Industries, LP has initiated a voluntary Class I recall of several models of reprocessed Abbott Inquiry Steerable Diagnostic Catheters. The recall was prompted by the discovery that certain lots may contain small particles of residual material. This is an expansion of a previous recall (Z-2610/2614-2025).
Which Products Are Affected
The recall involves 311 units distributed nationwide across the United States. All affected products are associated with Lot EP250618. The specific models and UDI-DIs include:
- 81105RH / 81172RH: 10 Elec. 2-5-2mm (UDI-DI 10197344133253, 10197344133284)
- 81202RH: 20 Elec. 2-10-2mm (UDI-DI 10197344133307)
- 81483RH: 4 Elec. 5mm (UDI-DI 10197344133444)
- 81102RH / 81104RH / 81174RH / 81531RH / 81532RH: 10 Elec. 2-5-2mm (UDI-DI 10197344133239, 10197344133246, 10197344133291, 10197344133512, 10197344133529)
- 81107RH: 10 Elec. 5mm (UDI-DI 10197344133260)
- 81402RH / 81404RH / 81405RH / 81474RH: 4 Elec. 2-5-2mm (UDI-DI 10197344133352, 10197344133376, 10197344133383, 10197344133437)
- 81473RH: 4 Elec. 5mm (UDI-DI 10197344133420)
What You Should Do
Medline Industries began notifying customers of the issue via letter on December 22, 2025. Healthcare facilities and providers should immediately check their inventory for the affected lot number (EP250618) and follow the instructions provided in the firm's notification letter regarding the return or disposal of the devices. For more information, contact Medline Industries, LP at their Northfield, Illinois headquarters.
Why This Matters
This is a Class I recall, indicating that the use of these devices poses a serious health risk. The presence of residual material in the catheters can lead to inflammatory responses, systemic infections, or thrombus reactions, which may result in life-threatening conditions such as cerebral embolism, pulmonary embolism, or deep vein thrombosis.
Source
FDA Recall Event ID 98277 - Recall Number: Z-1320-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category